5389-16-2

Upstream product

• 2778-34-9 ethyl [(2S)-2-(benzyloxycarbonylamino)-3-phenylpropanoylamino]acetate 

Downstream Products

• 3392-14-1 N-tert-butoxycarbonyl-glycyl=>phenylalanyl=>glycine ethyl ester; N-tert-butoxycarbonyl-glycyl=>L-phenylalanyl=>glycine ethyl ester 
• 2073-59-8 ethyl N-benzyloxycarbonylglycyl-L-phenylalanylglycinate 
• 99592-96-8 H-Tyr-D-Arg-Phe-Gly-Tyr-Pro-Ser-NH₂ 
• 793626-17-2 D-Arg(Tos)-Phe-Gly-OEt 
• 90549-94-3 Boc-Tyr-D-Arg(Tos)-Phe-Gly-O-n-Pr 
• 99597-91-8 H-Tyr-D-Arg-Phe-Gly-OEt 
• 99597-92-9 H-Tyr-D-Arg-Phe-Gly-n-OPr 
• 99597-63-4 Boc-Tyr-D-Arg(Tos)-Phe-Gly-Tyr-Pro-Ser-NH₂ 
• 90549-90-9 Boc-Tyr-D-Arg(Tos)-Phe-Gly-OH 
• 90549-88-5 Boc-Tyr-D-Arg(Tos)-Phe-Gly-OEt 
• 99592-91-3 H-Tyr-D-Arg-Phe-Gly-OH 

Relevant academic research and scientific papers

Studies on analgesic oligopeptides. III. Synthesis and analgesic activity after subcutaneous administration of [D-Arg2]dermorphin and its N-terminal tetrapeptide analogs

[D-Arg2]dermorphin and nineteen N-terminal tetrapeptide analogs were synthesized by a conventional solution method and their analgesic activities after subcutaneous administration to mice were examined. The analgesic effect was assessed by mean